Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,595.77
(
0.20%
)
US TECH 100
23,469.60
(
0.30%
)
Dow Jones
46,578.69
(
0.16%
)
Brent Oil
106.38
(
-2.56%
)
Bitcoin
69,553.61
(
0.79%
)
News Focus
News Focus
Post# of 257360
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

vinmantoo

Send PM Follow Ignore
Followers 28
Posts 4692
Boards Moderated 0
Alias Born 07/25/2007

vinmantoo

Re: DewDiligence post# 224764

Friday, 04/26/2019 1:31:16 AM

Friday, April 26, 2019 1:31:16 AM

Post# of 257360

GILD’s (second) Selonsertib phase-3 failure in NASH—this time in F3-fibrosis patients:



The carnage surrounding NASH drug development is starting to resemble that of companies attacking Alzheimers. It makes one wonder if they are on the right track.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today